NASD | Health Care | Biotechnology

Alector Inc. (ALEC)

LAST (2 Apr, 12:34 PM ET)
1.21
+0.05  (+4.31%)
Extended HOURS (00:00 PM ET)
-
-  (+000.00%)
MARKET CAP
120.285 M
VOLUME
113,849
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 2 Apr, 12:34 PM ET
Open 1.18
Previous Close 1.16
Day Range 1.13 - 1.22
52-Week Range 1.16 - 6.78
All-Time High 43.32
Avg. Volume (50-day) 640,144.06
EPS (TTM) -1.24
Next Earnings Date 2025-05-08 (AMC)
Last Earnings Date 2025-02-26
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -0.94
PEG Ratio 1.31
Price to Book 0.91
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 100.56 M
Revenue per Share (TTM) 1.02
Shares Outstanding 99.086 M
Share Float (%) 74.94 M (75.63%)
% Held by Institutions 68.31
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 1.36 (-11.03%)
+/- SMA(50) 1.56 (-22.44%)
+/- SMA(200) 3.64 (-66.76%)
5-Day Perf. -6.92%
1-Month Perf. -26.22%
3-Month Perf. -35.98%
6-Month Perf. -73.11%
YTD Perf. -35.98%
1-Year Perf. -79.21%
RSI(14) 36.34
ATR(14) 0.11
ADX(14) 15.6
Beta (5Y) 1.50
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

ALEC

7.5
(+0.0)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Alector Inc.

131 Oyster Point Boulevard, Suite 600
South San Francisco, California
http://www.alector.com
Sector: Health Care
Industry: Biotechnology
Employees: 238
Description

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Alerts for ALEC View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with ALEC

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.